To do this, we FACS-isolated the CD11b+ and CD49a+ NK cells from MC38 tumors and tested their ability to lyse B16-F10 tumor cells in vitro over 4 h (Fig. 3I). This evidence concerns the gene ITGAM and neoplasm.